Tackling STI testing, Readily Diagnostics raises €811k for affordable alternative
Readily Diagnostics, a Swedish point-of-care diagnostics company, has received a grant of approximately €811k (about 9 million SEK) from the Gates Foundation to develop an affordable test for the world’s most common sexually transmitted infections (STIs). The funding will support early concept and feasibility work for a point-of-care test covering chlamydia, gonorrhea and trichomoniasis,…
Swedish point-of-care diagnostics company Readily Diagnostics has secured a €811k grant from the Gates Foundation to develop an affordable test for the three most common sexually transmitted infections (STIs): chlamydia, gonorrhea, and trichomoniasis. The funding will support early-stage feasibility work for a point-of-care test, including sample preparation, antimicrobial resistance detection, and product development.
CEO Liza Löf emphasized Readily's commitment to accessible molecular diagnostics, stating that accurate testing should not depend on a patient's location. The grant comes amid increased funding for decentralised and rapid diagnostics startups in Europe in 2026, with EU-Startups reporting €34 million across related announcements.
Readily Diagnostics, founded in 2022 and spun out of Uppsala University, focuses on sensitive, specific, and rapid diagnostic testing for infectious diseases. The company's goal is to provide a point-of-care platform for STI testing that delivers molecular diagnostic results close to the patient, eliminating the need for central laboratories, and detecting genetic markers of antibiotic resistance.
This approach aims to improve treatment outcomes, prevent overuse of antibiotics, and halt the development of drug resistance.
Written by urgent.news from EU-Startups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
